Partnering with Fieldstone Bio: Harnessing Living Sensors with Synthetic Biology & Hyperspectral Imaging to Revolutionize Chemical & Environmental Monitoring

/
Partnering with Fieldstone Bio: Harnessing Living Sensors with Synthetic Biology & Hyperspectral Imaging to Revolutionize Chemical & Environmental Monitoring

We are thrilled to partner with Fieldstone Bio because their microbial sensors can identify targets in the environment at massive scales. Existing methods rely on bulky, expensive equipment and lab processing that takes significant time. Fieldstone Bio's breakthrough enables faster remote sensing using off-the-shelf hyperspectral cameras.

We at LDV Capital participated in their $5M seed round led by Ubiquity Ventures and with participation from E14 Fund.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

/
The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

/
The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

On March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society. 

In the lead-up to the Summit, Evan had the privilege of asking Dr. Gibson a few questions.

Read More